logo

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

Endocyte, Inc.


USPTO Granted Patents = 60

% Expired Patents = 53.3



Trademarks = 2

Forward Citations = 795

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 111 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

6.  Joseph Anand Reddy (8 out of 8 patents)

7.  Kevin Yu Wang (8 out of 8 patents)

8.  Fei You (7 out of 7 patents)

9.  Yingjuan June Lu (7 out of 9 patents)

10.  Matthew A Parker (7 out of 7 patents)

11.  Stephen J Howard (6 out of 43 patents)

12.  Apparao Satyam (6 out of 11 patents)

13.  Haiyan Chu (6 out of 7 patents)

14.  Marilynn Vetzel (4 out of 4 patents)

15.  Melissa Nelson (4 out of 4 patents)


Core Competencies:
CAR T Cells
PSMA Conjugates
Imaging Agents
Folate Receptor
Tumor Treatment
Drug Delivery
Conjugates
Vitamin Receptor
Multi-Drug Ligands
Tubulysins
Hydrophilic Spacer Linkers
Combination Therapies

60 patents:

1. 12473265 - Methods for preparing PSMA conjugates (2025-11-18),
2. 12269862 - Methods of use for CAR T cells (2025-04-08),
3. 12240870 - Sequencing method for CAR T cell therapy (2025-03-04),
4. 12208102 - Methods of treating cancer (2025-01-28),
5. 12178892 - Compounds for positron emission tomography (2024-12-31),
6. 12144850 - Methods and compositions for car T cell therapy (2024-11-19),
7. 11850262 - Compositions and methods for CAR T cell therapy (2023-12-26),
8. 11779602 - Methods of use for CAR T cells (2023-10-10),
9. 11759480 - Compositions and methods for CAR T cell therapy (2023-09-19),
10. 11219622 - Folate receptor binding conjugates of antifolates (2022-01-11),
11. 10912840 - Conjugates for treating diseases caused by PSMA expressing cells (2021-02-09),
12. 10898596 - Conjugates for imaging (2021-01-26),
13. 10857234 - Carbonic anhydrase IX inhibitor conjugates and uses thereof (2020-12-08),
14. 10738086 - Conjugates containing hydrophilic spacer linkers (2020-08-11),
15. 10647676 - Bivalent linkers and conjugates thereof (2020-05-12),
Endocyte, Inc. is a biopharmaceutical company based in West Lafayette, Indiana. The company is focused on developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte utilizes its proprietary technology platform to create small molecule drug conjugates (SMDCs), which specifically target diseased cells while minimizing impact on healthy cells. With a strong pipeline of potential therapeutics, Endocyte is dedicated to improving patient outcomes through innovative and personalized medicine.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Endocyte, Inc.
60 Patents

#5 in West Lafayette, IN

#103 in Indiana

#5,985 in US

#12,059 in the World

West Lafayette, IN (US)
West Lafayette, IN, United States of America

Endocyte, Inc.

Forward Citations = 795

50 inventors:

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 111 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

Please report any incorrect information to [email protected]
Loading…